(Q40114425)

17 September 2017

1 reference

title

Paget's disease of bone: diagnosis and management (English)

1 reference

17 September 2017

Paget's bloom of bone : Diagnosis and management (English)

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

31 August 2023

main subject

Paget's disease of bone

1 reference

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

31 August 2023

author

Robert Graham G Russell

3

object named as

R. G. Russell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220190

31 August 2023

author name string

J. A. Kanis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220190

31 August 2023

J. M. Evanson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220190

31 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6220190

31 August 2023

publication date

1 January 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0221874781900369?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

https://api.elsevier.com/content/article/PII:0221874781900369?httpAccept=text/plain

31 August 2023

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Metabolic bone disease & related research

31 August 2023

published in

1 reference

17 September 2017

volume

3

1 reference

17 September 2017

issue

4-5

1 reference

17 September 2017

page(s)

219-230

1 reference

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)

17 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Paget's Disease of the Bone: Observations After Cessation of Long-Term Synthetic Salmon Calcitonin Treatment

31 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Salmon and porcine calcitonin treatment of Paget's disease of bone

31 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effect of a Diphosphonate on Para-Articular Ossification after total Hip Replacement

31 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

31 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Diphosphonate Therapy of Paget's Disease of Bone

31 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

31 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.

31 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone

31 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

31 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Healing of the bones in juvenile Paget's disease treated by human calcitonin

31 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

A Cheap Oral Therapy for Paget's Disease of Bone

31 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Calcitonin Resistance: Clinical and Immunologic Studies in Subjects with Paget's Disease of Bone Treated with Porcine and Salmon Calcitonins

31 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Paget's bone disease treated with diphosphonate and calcitonin

31 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Metabolic Effects of Diphosphonate in Primary Hyperparathyroidism

31 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results

31 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effect of the Diphosphonate EHDP on Bone Mineral Metabolism During Prolonged Bed Rest

31 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Improvement in paraplegia in vertebral Paget's disease treated with calcitonin

31 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

31 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Nuclear inclusions in Paget's disease of bone

31 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Calcitonin or diphosphonates for osteolytic Paget's disease?

31 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Diphosphonates in Paget's disease

31 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Long-term therapy of Paget's disease of bone with EHDP

31 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

31 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Diphosphonates and Page's disease of bone.

31 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report)

31 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

31 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation

31 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0221-8747(81)90036-9

31 August 2023

Identifiers

1 reference

17 September 2017

1 reference